{"id":5295,"date":"2024-07-02T12:44:00","date_gmt":"2024-07-02T10:44:00","guid":{"rendered":"https:\/\/ami.ryveniaservices.eu\/erste-atoms-patienten-in-frankreich-behandelt\/"},"modified":"2024-09-16T10:55:15","modified_gmt":"2024-09-16T08:55:15","slug":"erste-atoms-patienten-in-frankreich-behandelt","status":"publish","type":"post","link":"https:\/\/ami.at\/de\/erste-atoms-patienten-in-frankreich-behandelt\/","title":{"rendered":"Erste ATOMS-Patienten in Frankreich behandelt"},"content":{"rendered":"\n<figure class=\"wp-block-image size-large\"><img fetchpriority=\"high\" decoding=\"async\" width=\"1024\" height=\"538\" src=\"https:\/\/ami.at\/wp-content\/uploads\/2024\/07\/ATOMS_FR_first-patients_EN-1024x538.jpg\" alt=\"\" class=\"wp-image-1764\" srcset=\"https:\/\/ami.at\/wp-content\/uploads\/2024\/07\/ATOMS_FR_first-patients_EN-1024x538.jpg 1024w, https:\/\/ami.at\/wp-content\/uploads\/2024\/07\/ATOMS_FR_first-patients_EN-300x158.jpg 300w, https:\/\/ami.at\/wp-content\/uploads\/2024\/07\/ATOMS_FR_first-patients_EN-768x403.jpg 768w, https:\/\/ami.at\/wp-content\/uploads\/2024\/07\/ATOMS_FR_first-patients_EN.jpg 1200w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n\n<p>Erste ATOMS-Patienten in Frankreich behandelt<br\/>Letzte Woche gab es einen bedeutenden Fortschritt f\u00fcr M\u00e4nner, die mit Harninkontinenz zu k\u00e4mpfen haben. Zwei franz\u00f6sische Patienten, die zuvor nach einer Prostatastrahlentherapie unter Harninkontinenz gelitten hatten, erlebten einen entscheidenden Wendepunkt, als sie die ersten Personen wurden, die von der innovativen ATOMS-Technologie von A.M.I. profitierten.<br\/>A.M.I. Frankreich m\u00f6chte insbesondere Professor Beno\u00eet Peyronnet von der urologischen Abteilung des Universit\u00e4tsklinikums Rennes und Dr. Fabian Queissert von der urologischen Abteilung des Universit\u00e4tsklinikums M\u00fcnster in Deutschland danken. Ihr Fachwissen und der engagierte Einsatz des gesamten Teams der Universit\u00e4tsklinik Rennes waren entscheidend f\u00fcr die erfolgreiche Implantation dieser Ger\u00e4te und ebneten den Weg f\u00fcr diese bahnbrechenden Eingriffe.<br\/>Wir laden Sie herzlich ein, diesen historischen Meilenstein gemeinsam mit uns an unserem Stand K66 w\u00e4hrend des EAU-Kongresses in Paris vom 5. bis 8. April zu feiern. Lassen Sie uns gemeinsam diesen bedeutenden Erfolg w\u00fcrdigen.  <\/p>\n","protected":false},"excerpt":{"rendered":"<p>Erste ATOMS-Patienten in Frankreich behandeltLetzte Woche gab es einen bedeutenden Fortschritt f\u00fcr M\u00e4nner, die mit Harninkontinenz zu k\u00e4mpfen haben. Zwei franz\u00f6sische Patienten, die zuvor nach einer Prostatastrahlentherapie unter Harninkontinenz gelitten hatten, erlebten einen entscheidenden Wendepunkt, als sie die ersten Personen wurden, die von der innovativen ATOMS-Technologie von A.M.I. profitierten.A.M.I. Frankreich m\u00f6chte insbesondere Professor Beno\u00eet Peyronnet [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":4901,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[63],"tags":[],"class_list":["post-5295","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news-de"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v23.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Erste ATOMS-Patienten in Frankreich behandelt - A.M.I. \u2013 Agency for Medical Innovations<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ami.at\/de\/erste-atoms-patienten-in-frankreich-behandelt\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Erste ATOMS-Patienten in Frankreich behandelt - A.M.I. \u2013 Agency for Medical Innovations\" \/>\n<meta property=\"og:description\" content=\"Erste ATOMS-Patienten in Frankreich behandeltLetzte Woche gab es einen bedeutenden Fortschritt f\u00fcr M\u00e4nner, die mit Harninkontinenz zu k\u00e4mpfen haben. Zwei franz\u00f6sische Patienten, die zuvor nach einer Prostatastrahlentherapie unter Harninkontinenz gelitten hatten, erlebten einen entscheidenden Wendepunkt, als sie die ersten Personen wurden, die von der innovativen ATOMS-Technologie von A.M.I. profitierten.A.M.I. Frankreich m\u00f6chte insbesondere Professor Beno\u00eet Peyronnet [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ami.at\/de\/erste-atoms-patienten-in-frankreich-behandelt\/\" \/>\n<meta property=\"og:site_name\" content=\"A.M.I. \u2013 Agency for Medical Innovations\" \/>\n<meta property=\"article:published_time\" content=\"2024-07-02T10:44:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-09-16T08:55:15+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ami.ryveniaservices.eu\/wp-content\/uploads\/2024\/07\/ATOMS_FR_first-patients_EN.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"630\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"ryveniadev\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Verfasst von\" \/>\n\t<meta name=\"twitter:data1\" content=\"ryveniadev\" \/>\n\t<meta name=\"twitter:label2\" content=\"Gesch\u00e4tzte Lesezeit\" \/>\n\t<meta name=\"twitter:data2\" content=\"1\u00a0Minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/ami.at\/de\/erste-atoms-patienten-in-frankreich-behandelt\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ami.at\/de\/erste-atoms-patienten-in-frankreich-behandelt\/\"},\"author\":{\"name\":\"ryveniadev\",\"@id\":\"https:\/\/ami.ryveniaservices.eu\/#\/schema\/person\/ceddd94a3cd427cccfcdf8fabbed2f00\"},\"headline\":\"Erste ATOMS-Patienten in Frankreich behandelt\",\"datePublished\":\"2024-07-02T10:44:00+00:00\",\"dateModified\":\"2024-09-16T08:55:15+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ami.at\/de\/erste-atoms-patienten-in-frankreich-behandelt\/\"},\"wordCount\":162,\"publisher\":{\"@id\":\"https:\/\/ami.ryveniaservices.eu\/#organization\"},\"image\":{\"@id\":\"https:\/\/ami.at\/de\/erste-atoms-patienten-in-frankreich-behandelt\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ami.at\/wp-content\/uploads\/2024\/07\/ATOMS_FR_first-patients_EN.jpg\",\"articleSection\":[\"News\"],\"inLanguage\":\"de\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ami.at\/de\/erste-atoms-patienten-in-frankreich-behandelt\/\",\"url\":\"https:\/\/ami.at\/de\/erste-atoms-patienten-in-frankreich-behandelt\/\",\"name\":\"Erste ATOMS-Patienten in Frankreich behandelt - A.M.I. \u2013 Agency for Medical Innovations\",\"isPartOf\":{\"@id\":\"https:\/\/ami.ryveniaservices.eu\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ami.at\/de\/erste-atoms-patienten-in-frankreich-behandelt\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ami.at\/de\/erste-atoms-patienten-in-frankreich-behandelt\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ami.at\/wp-content\/uploads\/2024\/07\/ATOMS_FR_first-patients_EN.jpg\",\"datePublished\":\"2024-07-02T10:44:00+00:00\",\"dateModified\":\"2024-09-16T08:55:15+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/ami.at\/de\/erste-atoms-patienten-in-frankreich-behandelt\/#breadcrumb\"},\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ami.at\/de\/erste-atoms-patienten-in-frankreich-behandelt\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\/\/ami.at\/de\/erste-atoms-patienten-in-frankreich-behandelt\/#primaryimage\",\"url\":\"https:\/\/ami.at\/wp-content\/uploads\/2024\/07\/ATOMS_FR_first-patients_EN.jpg\",\"contentUrl\":\"https:\/\/ami.at\/wp-content\/uploads\/2024\/07\/ATOMS_FR_first-patients_EN.jpg\",\"width\":1200,\"height\":630},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ami.at\/de\/erste-atoms-patienten-in-frankreich-behandelt\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ami.at\/de\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"News\",\"item\":\"https:\/\/ami.at\/de\/category\/news-de\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Erste ATOMS-Patienten in Frankreich behandelt\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ami.ryveniaservices.eu\/#website\",\"url\":\"https:\/\/ami.ryveniaservices.eu\/\",\"name\":\"A.M.I. \u2013 Agency for Medical Innovations\",\"description\":\"Austrian manufacturer of medical technology\",\"publisher\":{\"@id\":\"https:\/\/ami.ryveniaservices.eu\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ami.ryveniaservices.eu\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"de\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/ami.ryveniaservices.eu\/#organization\",\"name\":\"A.M.I. \u2013 Agency for Medical Innovations\",\"url\":\"https:\/\/ami.ryveniaservices.eu\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\/\/ami.ryveniaservices.eu\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/ami.at\/wp-content\/uploads\/2024\/07\/Logo_A.M.I._claim_Pantone.png\",\"contentUrl\":\"https:\/\/ami.at\/wp-content\/uploads\/2024\/07\/Logo_A.M.I._claim_Pantone.png\",\"width\":1081,\"height\":469,\"caption\":\"A.M.I. \u2013 Agency for Medical Innovations\"},\"image\":{\"@id\":\"https:\/\/ami.ryveniaservices.eu\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/ami.ryveniaservices.eu\/#\/schema\/person\/ceddd94a3cd427cccfcdf8fabbed2f00\",\"name\":\"ryveniadev\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\/\/ami.ryveniaservices.eu\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/81aa5318de18584b6af9bf083078ea4bff4503177f9715e21a1a9c567ff28b81?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/81aa5318de18584b6af9bf083078ea4bff4503177f9715e21a1a9c567ff28b81?s=96&d=mm&r=g\",\"caption\":\"ryveniadev\"},\"sameAs\":[\"https:\/\/ami.at\"],\"url\":\"https:\/\/ami.at\/de\/author\/ryveniadev\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Erste ATOMS-Patienten in Frankreich behandelt - A.M.I. \u2013 Agency for Medical Innovations","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ami.at\/de\/erste-atoms-patienten-in-frankreich-behandelt\/","og_locale":"de_DE","og_type":"article","og_title":"Erste ATOMS-Patienten in Frankreich behandelt - A.M.I. \u2013 Agency for Medical Innovations","og_description":"Erste ATOMS-Patienten in Frankreich behandeltLetzte Woche gab es einen bedeutenden Fortschritt f\u00fcr M\u00e4nner, die mit Harninkontinenz zu k\u00e4mpfen haben. Zwei franz\u00f6sische Patienten, die zuvor nach einer Prostatastrahlentherapie unter Harninkontinenz gelitten hatten, erlebten einen entscheidenden Wendepunkt, als sie die ersten Personen wurden, die von der innovativen ATOMS-Technologie von A.M.I. profitierten.A.M.I. Frankreich m\u00f6chte insbesondere Professor Beno\u00eet Peyronnet [&hellip;]","og_url":"https:\/\/ami.at\/de\/erste-atoms-patienten-in-frankreich-behandelt\/","og_site_name":"A.M.I. \u2013 Agency for Medical Innovations","article_published_time":"2024-07-02T10:44:00+00:00","article_modified_time":"2024-09-16T08:55:15+00:00","og_image":[{"width":1200,"height":630,"url":"https:\/\/ami.ryveniaservices.eu\/wp-content\/uploads\/2024\/07\/ATOMS_FR_first-patients_EN.jpg","type":"image\/jpeg"}],"author":"ryveniadev","twitter_card":"summary_large_image","twitter_misc":{"Verfasst von":"ryveniadev","Gesch\u00e4tzte Lesezeit":"1\u00a0Minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ami.at\/de\/erste-atoms-patienten-in-frankreich-behandelt\/#article","isPartOf":{"@id":"https:\/\/ami.at\/de\/erste-atoms-patienten-in-frankreich-behandelt\/"},"author":{"name":"ryveniadev","@id":"https:\/\/ami.ryveniaservices.eu\/#\/schema\/person\/ceddd94a3cd427cccfcdf8fabbed2f00"},"headline":"Erste ATOMS-Patienten in Frankreich behandelt","datePublished":"2024-07-02T10:44:00+00:00","dateModified":"2024-09-16T08:55:15+00:00","mainEntityOfPage":{"@id":"https:\/\/ami.at\/de\/erste-atoms-patienten-in-frankreich-behandelt\/"},"wordCount":162,"publisher":{"@id":"https:\/\/ami.ryveniaservices.eu\/#organization"},"image":{"@id":"https:\/\/ami.at\/de\/erste-atoms-patienten-in-frankreich-behandelt\/#primaryimage"},"thumbnailUrl":"https:\/\/ami.at\/wp-content\/uploads\/2024\/07\/ATOMS_FR_first-patients_EN.jpg","articleSection":["News"],"inLanguage":"de"},{"@type":"WebPage","@id":"https:\/\/ami.at\/de\/erste-atoms-patienten-in-frankreich-behandelt\/","url":"https:\/\/ami.at\/de\/erste-atoms-patienten-in-frankreich-behandelt\/","name":"Erste ATOMS-Patienten in Frankreich behandelt - A.M.I. \u2013 Agency for Medical Innovations","isPartOf":{"@id":"https:\/\/ami.ryveniaservices.eu\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ami.at\/de\/erste-atoms-patienten-in-frankreich-behandelt\/#primaryimage"},"image":{"@id":"https:\/\/ami.at\/de\/erste-atoms-patienten-in-frankreich-behandelt\/#primaryimage"},"thumbnailUrl":"https:\/\/ami.at\/wp-content\/uploads\/2024\/07\/ATOMS_FR_first-patients_EN.jpg","datePublished":"2024-07-02T10:44:00+00:00","dateModified":"2024-09-16T08:55:15+00:00","breadcrumb":{"@id":"https:\/\/ami.at\/de\/erste-atoms-patienten-in-frankreich-behandelt\/#breadcrumb"},"inLanguage":"de","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ami.at\/de\/erste-atoms-patienten-in-frankreich-behandelt\/"]}]},{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/ami.at\/de\/erste-atoms-patienten-in-frankreich-behandelt\/#primaryimage","url":"https:\/\/ami.at\/wp-content\/uploads\/2024\/07\/ATOMS_FR_first-patients_EN.jpg","contentUrl":"https:\/\/ami.at\/wp-content\/uploads\/2024\/07\/ATOMS_FR_first-patients_EN.jpg","width":1200,"height":630},{"@type":"BreadcrumbList","@id":"https:\/\/ami.at\/de\/erste-atoms-patienten-in-frankreich-behandelt\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ami.at\/de\/"},{"@type":"ListItem","position":2,"name":"News","item":"https:\/\/ami.at\/de\/category\/news-de\/"},{"@type":"ListItem","position":3,"name":"Erste ATOMS-Patienten in Frankreich behandelt"}]},{"@type":"WebSite","@id":"https:\/\/ami.ryveniaservices.eu\/#website","url":"https:\/\/ami.ryveniaservices.eu\/","name":"A.M.I. \u2013 Agency for Medical Innovations","description":"Austrian manufacturer of medical technology","publisher":{"@id":"https:\/\/ami.ryveniaservices.eu\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ami.ryveniaservices.eu\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"de"},{"@type":"Organization","@id":"https:\/\/ami.ryveniaservices.eu\/#organization","name":"A.M.I. \u2013 Agency for Medical Innovations","url":"https:\/\/ami.ryveniaservices.eu\/","logo":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/ami.ryveniaservices.eu\/#\/schema\/logo\/image\/","url":"https:\/\/ami.at\/wp-content\/uploads\/2024\/07\/Logo_A.M.I._claim_Pantone.png","contentUrl":"https:\/\/ami.at\/wp-content\/uploads\/2024\/07\/Logo_A.M.I._claim_Pantone.png","width":1081,"height":469,"caption":"A.M.I. \u2013 Agency for Medical Innovations"},"image":{"@id":"https:\/\/ami.ryveniaservices.eu\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/ami.ryveniaservices.eu\/#\/schema\/person\/ceddd94a3cd427cccfcdf8fabbed2f00","name":"ryveniadev","image":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/ami.ryveniaservices.eu\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/81aa5318de18584b6af9bf083078ea4bff4503177f9715e21a1a9c567ff28b81?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/81aa5318de18584b6af9bf083078ea4bff4503177f9715e21a1a9c567ff28b81?s=96&d=mm&r=g","caption":"ryveniadev"},"sameAs":["https:\/\/ami.at"],"url":"https:\/\/ami.at\/de\/author\/ryveniadev\/"}]}},"_links":{"self":[{"href":"https:\/\/ami.at\/de\/wp-json\/wp\/v2\/posts\/5295","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ami.at\/de\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ami.at\/de\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ami.at\/de\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/ami.at\/de\/wp-json\/wp\/v2\/comments?post=5295"}],"version-history":[{"count":3,"href":"https:\/\/ami.at\/de\/wp-json\/wp\/v2\/posts\/5295\/revisions"}],"predecessor-version":[{"id":5298,"href":"https:\/\/ami.at\/de\/wp-json\/wp\/v2\/posts\/5295\/revisions\/5298"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ami.at\/de\/wp-json\/wp\/v2\/media\/4901"}],"wp:attachment":[{"href":"https:\/\/ami.at\/de\/wp-json\/wp\/v2\/media?parent=5295"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ami.at\/de\/wp-json\/wp\/v2\/categories?post=5295"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ami.at\/de\/wp-json\/wp\/v2\/tags?post=5295"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}